Drawing for IVY BIOSCIENCES

USPTO serial 98966481

IVY BIOSCIENCES

Reviewed by CopyMark Law Group

Status 641Office Action
Filing date
Status date
Registration date
Examiner
HOLLAND, JAMI ELENA

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Deadline: July 28th, 2026

Need help with IVY BIOSCIENCES?

CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.

Office Action issues

The USPTO has refused your application because your mark is too similar to existing registrations [7369276, 7867818], and they require a disclaimer for descriptive wording, a physical business address, and an updated description of your logo.

Owner

  • Ivy Biosciences LLC

    Nashville, TN, US

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for inducing erections; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, inducers of erectionsACTIVE
042Biological research; Biotechnology research; Genetic testing for scientific research purposes; Laboratory research in the field of pharmaceuticals; Medical research services; Pharmaceutical research and development; Pharmaceutical research services; Providing information about medical and scientific research via a website; Scientific research and developmentACTIVE

Prosecution history

DateCodeEvent
Jul 27, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jul 27, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Apr 28, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 28, 2026GNRTNON-FINAL ACTION E-MAILED
Apr 28, 2026CNRTNON-FINAL ACTION WRITTEN
Apr 10, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Apr 10, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 10, 2026ALIEASSIGNED TO LIE
Apr 7, 2026NREVNOTICE OF REVIVAL - E-MAILED
Apr 7, 2026PETGPETITION TO REVIVE-GRANTED
Mar 27, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 27, 2026PROATEAS PETITION TO REVIVE RECEIVED
Jan 28, 2026MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jan 28, 2026ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Sep 24, 2025XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Sep 24, 2025XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jul 15, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 15, 2025GNRTNON-FINAL ACTION E-MAILED
Jul 15, 2025CNRTNON-FINAL ACTION WRITTEN
Jun 24, 2025DOCKASSIGNED TO EXAMINER
Jun 17, 2025MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED
Jun 17, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 15, 2025NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance